XLXianlun Li

Xianlun Li

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Xianlun Li has a total of 96 co-authors. Here are the top co-authors by number of shared publications:

  • Mengru Liu

    Department of Integrative Medicine Cardiology, China-Japan Friendship Hospital (Institute of Clinical Medical Sciences), Beijing, China

    12 shared publications
  • Tong Gao

    Department of Integrative Medicine Cardiology, China-Japan Friendship Hospital (Institute of Clinical Medical Sciences), Beijing, China

    11 shared publications
  • Peng Yang

    Department of Integrative Medicine Cardiology, China-Japan Friendship Hospital, Beijing 100029, China

    10 shared publications
  • Baofu Wang

    Department of Integrative Medicine Cardiology, China-Japan Friendship Hospital (Institute of Clinical Medical Sciences), Beijing, China

    7 shared publications
  • Dongliang Fu

    Department of Cardiology, Integrated Traditional Chinese and Western Medicine, China-Japan Friendship Hospital, Beijing, China

    7 shared publications
  • Jiajie Yin

    Department of Integrative Medicine Cardiology, China-Japan Friendship Hospital, Beijing, China; Institute of Clinical Medical Sciences, China-Japan Friendship Hospital, Beijing, China

    7 shared publications

Latest Publications

  • Open Access

    Novel cardiometabolic indices and coronary microvascular dysfunction in intermediate stenosis: the role of AIP and TyG index

    by Danni Wu, Lin Zhao, Baofu Wang, Song Wu, Mengru Liu, Tong Gao, Xianlun Li

    Background: This study assessed the association between two emerging cardiometabolic indices—the atherogenic index of plasma (AIP) and triglyceride-glucose (TyG) index—and coronary microcirculation in patients with intermediate stenosis. Methods: This cross-sectional study included 566 consecutive patients with intermediate coronary stenosis treated at China-Japan Friendship Hospital between January 2023 and February 2024. Coronary microvascular dysfunction (CMD) was defined as an angiography-derived index of microcirculatory resistance (AMR) of ≥ 2.5. The AIP and TyG index were calculated from baseline laboratory data. All participants were categorized into tertiles based on each index. Results: A total of 407 patients (71.9%) were diagnosed with CMD. Restricted cubic spline analysis showed a linear association of both AIP and the TyG index with CMD. Multivariate logistic regression revealed that individuals in the highest tertile of each index had a significantly greater odds of CMD than those in the lowest tertile (AIP: odds ratio (OR) = 2.00, 95% confidence interval (CI) = 1.21–3.31, P = 0.007; TyG index: OR = 2.11, 95% CI = 1.26–3.53, P = 0.005). Subgroup analyses reveal a more pronounced relationship between AIP and CMD in the nonhypertensive subgroup ( P for interaction = 0.004). Receiver operating characteristic curve analysis showed comparable discriminatory ability between AIP and TyG index (the area under the curve: 0.567 vs. 0.559, DeLong test, P = 0.62). Conclusion: In patients with intermediate coronary stenosis, elevated AIP and TyG index were positively associated with CMD. Both indices may serve as potential adjunctive biomarkers for CMD in this population.

  • Allicin alleviates myocardial PANoptosis during ischemia-reperfusion by inhibiting TLR4 activation

    by Shichao Liang, Jiajie Yin, Yijie Gao, Fangyuan Luo, Song Wu, Danni Wu, Lin Zhao, Tong Gao, Mengru Liu, Hong Jiang, et al.

  • Open Access

    Comparative analysis of myocardial strain parameters in acute decompensated heart failure phenotypes: a cross-sectional study

    by Zhizhou Lin, Songyuan Yu, Jiajie Yin, Hong Jiang, Mengru Liu, Xianlun Li

    Objective: To investigate the differences in two-dimensional speckle tracking echocardiography (2D-STE) parameters among patients with different types of acute decompensated heart failure (ADHF) and their correlation with left ventricular ejection fraction (LVEF). Methods: Ninety-eight patients hospitalized due to ADHF were included in this study. Patients were divided into two subgroups based on their LVEF using a cutoff of ≤49%: heart failure with reduced ejection fraction (HFrEF) and heart failure with preserved ejection fraction (HFpEF). All patients underwent transthoracic echocardiography and 2D-STE. Results: Compared to the HFrEF group,the HFpEF group showed significantly higher absolute values of GLSA4C, GLSA2C, GLSA3C, and LV-GLS values ( P < 0.05), as well as higher absolute values of LASR-ED, LASRD-ED, LASRT-ED, RVFWSL, and RV4CSL values ( P < 0.05). The HFrEF subgroup had higher LAFI and LASI values compared to the HFpEF group ( P < 0.05). In the HFrEF subgroup, LVEF was negatively correlated with GLSA4C, GLSA2C, GLSA3C, LV-GLS, RVFWSL, RV4CSL, LASr-ED, LASrct-ED, as well as LAFI and LASI ( P < 0.05). However, LVEF was positively correlated with LASrcd-ED ( P < 0.05). In the HFpEF subgroup, LVEF was negatively correlated only with GLSA4C, GLSA2C, GLSA3C and LV-GLS ( P < 0.05). After controlling for related variables (LVEF), the correlations between LV-GLS and LASr-ED, LASrcd-ED, and LASrct-ED remained significant in both groups of heart failure patients ( P < 0.05). In HFrEF patients, the correlations between RVFWSL and LASr-ED, LASrcd-ED, and LASrct-ED disappeared ( P > 0.05). In HFpEF patients, RVFWSL was negatively correlated with LASr-ED ( P < 0.05), positively correlated with LASrct-ED ( P < 0.05), but its correlation with LASrcd-ED disappeared ( P > 0.05). Conclusion: Significant differences exist in 2D-STE parameters between the HFrEF and HFpEF groups, and LVEF correlates with these parameters. After adjusting for LVEF, LV-GLS remains correlated with various parameters in different heart failure groups. Our findings suggest a stronger interdependence between right ventricular and left atrial mechanics in HFpEF patients compared to HFrEF patients, evidenced by the persistence of correlations between RV free wall strain and LA reservoir/pump strain after adjusting for LVEF.

  • Inhibition of toll-like receptor 4 by allicin suppresses mitochondrial DNA-mediated inflammation and pyroptosis to alleviate myocardial ischemia-reperfusion injury

    by Shichao Liang, Song Wu, Jiajie Yin, Tong Gao, Mengru Liu, Yijie Gao, Fangyuan Luo, Danni Wu, Songyuan Yu, Lin Zhao, et al.


  • The relationship between eGFR difference and in-hospital mortality in acute coronary syndrome patients stratified by chronic kidney disease

    by Fangyuan Luo, Songyuan Yu, Jiajie Yin, Danni Wu, Song Wu, Tong Gao, Mengru Liu, Xianlun Li

  • Open Access

    Glomerular Filtration Rate by Differing Measures in Predicting Atrial Fibrillation Recurrence After Ablation

    by Fangyuan Luo, Zhe Wang, Jiajie Yin, Danni Wu, Song Wu, Jianzeng Dong, Yingwei Chen, Xianlun Li

    Background: Significant differences often exist between estimated glomerular filtration rates (eGFR) calculated using various biomarkers. However, the relationship between these eGFR methods and atrial fibrillation (AF) recurrence after radiofrequency catheter ablation (RFCA) remains unclear. Methods: Thus, this study employed a retrospective analysis of 523 patients with AF who underwent an initial RFCA between July 2019 and October 2022. The eGFR was calculated using three methods based on the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) formula: serum creatinine (eGFRcr), serum cystatin C (eGFRcys), and a combination of both (eGFRcrcys). Cox regression models were used to explore the relationship between eGFR and AF recurrence. Results: Over a 1-year follow-up period, 174 (33.3%) patients experienced AF recurrence after RFCA. Multivariable Cox regression analysis indicated that only eGFRcys showed a consistent, significant inverse association with AF recurrence (hazard ratio (HR) = 0.990, 95% confidence interval (CI): 0.982–0.998, p = 0.019). In contrast, eGFRcrcys showed borderline significance after full adjustment (p = 0.067). Meanwhile, stratifying by optimal cutoff values identified an association for eGFRcys ≤64.280 mL/min/1.73 m2, and eGFRcrcys ≤76.093 mL/min/1.73 m2 with significantly higher recurrence risks after full adjustment (p = 0.008 and p = 0.036, respectively). Additionally, incorporating eGFRcys or eGFRcrcys into the baseline risk model led to a greater improvement in predictive accuracy than adding eGFRcr. Conclusions: The association between eGFR and AF recurrence after ablation appears to vary depending on the measurement methods; eGFRcys seems to provide the most reliable information. Incorporating eGFRcys into the pre-ablation risk stratification may enhance patient management and improve outcomes for patients undergoing AF ablation.


  • Open Access

    Nomogram for severe low-voltage areas prediction in older patients with paroxysmal atrial fibrillation: a retrospective cohort study

    by Song Wu, Xulong Zhao, Zhen Zhang, Zhengxian Tao, Xianlun Li, Hongwu Chen, Minglong Chen

    Low-voltage areas (LVA) are recognized as substrate for atrial fibrillation (AF) recurrence following pulmonary vein isolation. This study aimed to develop

  • Open Access

    Unveiling the Masquerading of Myocardial Bridging in Cardiovascular Diseases

    by Song Wu, Danni Wu, Xianlun Li

    Myocardial bridging (MB) is a congenital coronary artery anomaly initially regarded as a benign anatomical variant. However, an increasing number of studies have revealed the association between MB and various cardiovascular diseases. The primary pathological mechanisms underlying the relationship include dynamic mechanical compression leading to myocardial ischemia, coronary vasospasm, and the development of proximal atherosclerosis. Advancement of coronary artery imaging technology has enhanced the understanding of the anatomical and hemodynamic features of MB. Although treatment strategies are primarily symptom-driven, morphological and functional evaluation of MB in patients with asymptomatic concomitant cardiovascular diseases is recommended. Pharmacological therapy and management of cardiovascular conditions are the first-line approach. Invasive treatments strategies should be tailored to individual circumstances. This review examines the relationship between MB and other cardiovascular conditions, such as hypertrophic cardiomyopathy (HCM), coronary atherosclerosis, and myocardial ischemia with non-obstructive coronary arteries (INOCA) or myocardial infarction with non-obstructive coronary arteries (MINOCA). It provides an overview of the underlying mechanisms, diagnostic assessments, and treatment strategies. However, large-scale randomized controlled trials are needed to validate these findings.


  • Open Access

    Impact of Hemoglobin and Iron Deficiency on Mortality in Patients with Acute Myocardial Infarction in Intensive Care Units: A Retrospective Study from MIMIC-IV

    by Fangyuan Luo, Zhe Wang, Tong Gao, Baofu Wang, Yijie Gao, Mengru Liu, Hong Jiang, Xianlun Li

    Background: Anemia and iron deficiency (ID) are common in patients with acute myocardial infarction (AMI), especially those in intensive care units (ICU). This study investigated the impact of hemoglobin (Hb) and ID on the short-term mortality of critically ill patients with AMI. Methods: Overall 992 AMI patients with their first ICU admission were included in this analysis. ID was defined as serum ferritin <100 ng/mL or transferrin saturation (TSAT) <20%. Patients were categorized into four groups according to their Hb concentrations and the presence of ID. Kaplan-Meier survival analysis was used to assess differences in all-cause mortality between the different groups, and Cox regression models to identify risk factors for all-cause mortality. Results: Anemia was present in 89.5% of patients, while 65.9% suffered from ID. Patients in the group with Hb <9 g/dL and without ID were the youngest, yet they exhibited the highest severity scores. The Kaplan–Meier analysis showed that this group had a higher rate of all-cause mortality compared to the other three groups (Log-rank test p = 0.005). Moreover, multivariate Cox regression analysis revealed that Hb <9 g/dL and no ID was associated with a higher risk of all-cause mortality at 120 days (hazard ratio 1.512, 95% confidence interval 1.031–2.217, p = 0.034) when compared to the reference group (Hb ≥9 g/dL and no ID). Additionally, multivariate Cox regression analysis showed that lower Hb was linked to increased rates of all-cause mortality at 30, 60, 90, and 120 days. Elevated levels of ferritin and TSAT were also associated with increased all-cause mortality at 60, 90, and 120 days. Compared to patients without ID, those with ID had a decreased risk of all-cause mortality at 60, 90, and 120 days. Conclusions: Anemia and ID were prevalent in ICU patients with AMI. Patients with Hb <9 g/dL and without ID showed higher 120-day all-cause mortality. Additionally, lower Hb, elevated ferritin, and increased TSAT levels were identified as significant risk factors for short-term all-cause mortality in these patients.


  • The efficacy and mechanisms of Maiguanfukang Tablets, a patented herbal-based TCM formula, for the treatment of atherosclerosis: An in vivo experiment based on the network pharmacology

    by Baofu Wang, Tong Li, Fachang Zhang, Shujie Miao, Shiqi Chen, Yang Li, Yizhou Zhao, Xiaowan Han, Xianlun Li, Mingjing Zhao